Identification of MGMT promoter methylation as a specific lipid metabolism biomarker, reveals the feasibility of atorvastatin application in glioblastoma
Zhaonian Hao, Jiejun Wang, Yifan Lv, Weiqi Wu, Shaodong Zhang, Shuyu Hao, Junsheng Chu, Hong Wan, Jie Feng, Nan Ji
Topics & Concepts
GlioblastomaAtorvastatinBiomarkerMethylationIdentification (biology)Lipid metabolismCancer researchComputational biologyBiologyGenePharmacologyBiochemistryBotanyCancer, Lipids, and MetabolismGlioma Diagnosis and TreatmentCancer, Hypoxia, and Metabolism